Skip to main content
A Plus Biotech logo

A Plus Biotech — Investor Relations & Filings

Ticker · 6918 ISIN · TW0006918006 TW Manufacturing
Open in API
Filings indexed 26 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 6918

About A Plus Biotech

https://www.aplusbio.com/

Aplus Biotechnology Co., Ltd. specializes in the research, development, and production of orthopedic trauma solutions. The company distinguishes itself through its 'Asian Specific Curve' design philosophy, which tailors orthopedic implants to the unique anatomical bone curvatures of Asian populations. This specialized approach aims to enhance fracture reduction stability while minimizing soft tissue irritation and post-operative complications. Its product portfolio includes bone plate and screw systems, mini volar plates (MVP), trochanteric hip systems (THS), and advanced 3D-printed Patient Specific Instruments (PSI). Additionally, the company provides specialized solutions for knee preservation and degenerative arthritis. By collaborating with clinical and academic experts, Aplus integrates real-world surgical experience into its manufacturing processes to deliver high-precision implants and professional surgical support.

Recent filings

Filing Released Lang Actions
115年第1季財務報告書 — 202601_6918_AI1.pdf
Interim / Quarterly Report Classification · 97% confidence The document is titled as a “合併財務報告暨會計師核閱報告” for the first quarter of years 115 and 114 (i.e., Q1 interim financial statements with auditor’s review). It contains full consolidated balance sheets, income statements, cash flow statements, equity statements, accompanying notes, and auditor’s review report. It meets the definition of a comprehensive financial report for a period shorter than a full fiscal year. Therefore, this is an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
公告本公司董事會通過115年度第一季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a formal disclosure on the public information observatory announcing that the board of directors has approved the consolidated financial report for the first quarter (115/01/01–115/03/31). It contains actual quarterly financial data (cumulative revenue, gross profit, operating profit, pre‐tax profit, net profit, EPS, total assets, liabilities, equity). This is not merely a brief press release but an interim/quarterly financial report with substantive numeric details. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document is a standalone consolidated statement of changes in equity for the first quarter (“民國115年第1季”) and the prior year quarter, with actual financial figures in NTD thousands. It is not merely an announcement or certification nor a full annual report, but rather part of an interim/quarterly submission containing substantive financial data. Therefore, it fits the category “Interim / Quarterly Report” (IR). Q1 2026
2026-05-14 Chinese
115年第1季現金流量表
Interim / Quarterly Report Classification · 80% confidence The document is a consolidated cash flow statement for the first quarter of the company’s fiscal year (ROC 115 Q1, equivalent to Jan–Mar 2026), containing detailed line‐item financial data. It is part of a substantive interim/quarterly financial report rather than an announcement of publication or a summary highlight. Therefore it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季綜合損益表
Interim / Quarterly Report Classification · 90% confidence The document is a detailed Consolidated Comprehensive Income Statement for the company’s first quarter (Q1) of the fiscal year, showing full line‐by‐line financial results (revenues, costs, profits, EPS) for 115/01/01–115/03/31 versus the prior year period. It contains substantive financial data and analysis rather than merely announcing or attaching a report. This matches an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 94% confidence The document is a standalone consolidated balance sheet (“合併資產負債表”) for the first quarter (115年第1季) with actual financial statement line items and figures. It is part of the quarterly/interim financial statements rather than just an announcement. Thus, it qualifies as an Interim/Quarterly Report. Q1 2026
2026-05-14 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.